You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

NORGESIC FORTE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Norgesic Forte patents expire, and what generic alternatives are available?

Norgesic Forte is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in NORGESIC FORTE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORGESIC FORTE?
  • What are the global sales for NORGESIC FORTE?
  • What is Average Wholesale Price for NORGESIC FORTE?
Summary for NORGESIC FORTE
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:NORGESIC FORTE at DailyMed
Drug patent expirations by year for NORGESIC FORTE

US Patents and Regulatory Information for NORGESIC FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch NORGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 013416-004 Oct 27, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.